Company

The Ritedose Corporation

The Ritedose Corporation is a Columbia, US contract manufacturer of sterile inhalation solutions using Blow-Fill-Seal technology.

About

Founded in 1995 and headquartered in Columbia, US, The Ritedose Corporation provides sterile contract development and manufacturing, mainly of inhalation solutions made with Blow-Fill-Seal technology. Its products include Cromolyn Sodium and Arformoterol Tartrate, and it has delivered over 12 billion doses. In January 2022 Novo Holdings acquired the company, and the latest round is listed as a USD 600.00 mn secondary buyout led by AGIC Capital. CEO Jody Chastain leads the company.

2Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in